GPR32 and gastric cancer: Genetic deletion of 15-lypoxygenase or of the RvD1 receptor GPR32 in gastric cancer cells led to an increase in the angiogenic and tumorigenic activities of those cells, therefore, demonstrating a protective role of those endogenous pathways involved in SPM production and action [94].